top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Drugs
Anticancer Drugs
Autore O’Boyle Niamh M
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (214 p.)
Soggetto non controllato graphene oxide
indole
androgens
cyclooxygenase-2
cyclooxygenase-1
heteropolysaccharide
drug conjugation
drug delivery
ellipticine
chemical linker
oesophageal cancer
antiproliferative activity
topoisomerase II
?-lactam
DSD
antibody
topoisomerase inhibitors
magnetic targeting
cisplatin resistance
steroidogenesis
[18F]FDG PET/CT
heterocyclic chemistry
dehydroepiandrosterone
antimitotic
3-vinylazetidin-2-ones
glioblastoma
and cancer therapy
intestinal mucositis
Combretastatin A-4
metabolism
anti-cancer drugs
maghemite
COX-1 inhibitor
anticancer
CYP17A1
conjugate and hybrid drugs
inflammation
snticancer drugs
P450c17
tumorigenesis
cisplatin
biomarker profiling
cancer drug design
tubulin
cytochrome P450
5-fluorouracil
prostate cancer
abiraterone
NCI screen
radiation
cancer immunotherapy
microtubule targeted drugs
cancer
treatment resistance
ISBN 3-03921-587-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367753903321
O’Boyle Niamh M  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer immunotherapy & immuno-monitoring : mechanism, treatment, diagnosis, and emerging tools / / topic editors: Chao Ma, Rong Fan and Antoni Ribas
Cancer immunotherapy & immuno-monitoring : mechanism, treatment, diagnosis, and emerging tools / / topic editors: Chao Ma, Rong Fan and Antoni Ribas
Autore Chao Ma
Pubbl/distr/stampa Frontiers Media SA, 2014
Descrizione fisica 1 online resource (97 pages) : illustrations; digital, PDF file(s)
Collana Frontiers Research Topics
Soggetto topico Oncology
Medicine
Health & Biological Sciences
Soggetto non controllato immune assessment
single cell analysis
cancer immunotherapy
tumor immunity
immune suppression
ISBN 9782889193806
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Cancer immunotherapy and immuno-monitoring
Record Nr. UNINA-9910137205703321
Chao Ma  
Frontiers Media SA, 2014
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cell Biology of Viral Infections
Cell Biology of Viral Infections
Autore Lozach Pierre-Yves
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (418 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato ectoderm
mesoderm
human development
embryogenesis
interferon response
interferon-induced genes
self-organizing map (SOM) data portrayal
epigenetic signature
embryoid body
TGF-β and Wnt/β-catenin pathway
interferon
tumor necrosis factor
STAT
interferon regulatory factor
antiviral
autoimmunity
inflammation
hepatitis C virus
HCV
erlin-1
erlin-2
host factor
endoplasmic reticulum
RNA replication
protein production
virus production
lipid droplet
TAP-GFP
fluorescent TAP platform
antigen presentation
MHC I
immune evasion
BoHV-1 UL49.5
virus
calcium channels
calcium pumps
virus–host interaction
Ebola virus
filovirus
inclusion bodies
NXF1
liquid organelles
mRNA export
cancer immunotherapy
oncolytic virus
herpes simplex virus
immune checkpoint inhibitor
angiogenesis inhibitor
rabies
uDISCO
3D imaging
rabies pathogenicity
astrocyte infection
metabolism
apoptosis
autophagy
HIV-1 spread
cell-free infection
cell–cell transmission
3D cultures
mathematical modeling
environmental restriction
CAD
pyrimidine synthesis
HEV
particle production
viral replication
virus entry
hantavirus
Tula virus
replication
factory
RNA synthesis
Golgi
stress granules
actin cytoskeleton
nucleocapsid transport
Arp2/3 complex
ERAP2
ERAP2/Iso3
microbial infections
alternative splicing
SARS-CoV-2
host cell response
coronavirus
MERS-CoV
SARS-CoV
sialic acid
Siglec
antiviral peptide
enveloped viruses
membrane phosphatidylserine
envelope disruption
membrane damage
antiviral autophagy
galectin
bacterial invasion
adenovirus
lysophagy
ESCRT machinery
cedar virus
henipavirus
fusion protein
endocytosis
biological activity
feline coronavirus
feline enteric coronavirus
FECV
feline infectious peritonitis virus
FIPV
feline intestinal organoids
alphaviruses
cell death
mosquito
tolerance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557135903321
Lozach Pierre-Yves  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Creatine Supplementation for Health and Clinical Diseases
Creatine Supplementation for Health and Clinical Diseases
Autore Kreider Richard B
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (562 p.)
Soggetto topico Research & information: general
Biology, life sciences
Food & society
Soggetto non controllato ergogenic aids
cellular metabolism
phosphagens
sarcopenia
cognition
diabetes
creatine synthesis deficiencies
concussion
traumatic brain injury
spinal cord injury
muscle atrophy
rehabilitation
pregnancy
immunity
anti-inflammatory
antioxidant
anticancer
creatine
nutritional supplements
fertility
newborn
development
brain injury
post-viral fatigue syndrome
chronic fatigue syndrome
GAA
creatine kinase
dietary supplements
exercise
skeletal muscle
glycemic control
type 2 diabetes mellitus
phosphorylcreatine
dietary supplement
ergogenic aid
youth
athletes
osteoporosis
osteosarcopenia
frailty
cachexia
innate immunity
adaptive immunity
inflammation
macrophage polarization
cytotoxic T cells
toll-like receptors
vascular pathology
cardiovascular disease
oxidative stress
vascular health
female
menstrual cycle
hormones
exercise performance
menopause
mood
children
height
BMI-for-age
stature-for-age
growth
phosphocreatine
creatine transporter
supplementation
treatment
heart
heart failure
ischemia
myocardial infarction
anthracycline
cardiac toxicity
energy metabolism
cell survival
bioinformatics
systems biology
cellular allostasis
dynamic biosensor
pleiotropic effects of creatine (Cr) supplementation
inflammatory bowel diseases (IBD)
ulcerative colitis
Crohn’s disease
creatine kinase (CK)
phosphocreatine (PCr)
creatine transporter (CrT)
intestinal epithelial cell protection
intestinal tissue protection
creatine perfusion
organ transplantation
Adenosine mono-phosphate (AMP)
activated protein kinase (AMPK)
liver kinase B1 (LKB1)
mitochondrial permeability transition pore (mPTP)
reactive oxygen species (ROS)
glucose transporter (GLUT)
T cell antitumor immunity
metabolic regulator
cancer immunotherapy
supplements
muscle damage
recovery
immobilization
atrophy
muscular dystrophy
amyotrophic lateral sclerosis
Parkinson’s Disease
cardiopulmonary disease
mitochondrial cytopathy
hypertrophy
athletic performance
weightlifting
resistance exercise
training
muscular power
muscular adaptation
muscle fatigue
adipose tissue
muscle strength
physiological adaptation
mitochondria
thermogenesis
MAP kinase signaling system
sodium-chloride-dependent neurotransmitter symporters
signal transduction
intradialytic creatine supplementation
hemodialysis
muscle
protein energy wasting
clinical trial
muscle weakness
chronic fatigue
cognitive impairment
depression
anemia
resistance training
sports nutrition
strength
toxicity
methylation
hyperhomocysteinemia
neuromodulation
MCDA
mitochondriopathia
cardiac infarction
long COVID
hypoxia
stroke
neurodegenerative diseases
noncommunicable disease
adenosine 5′-monopnophosphate-activated protein kinase
anthracyclines
creatine supplementation
cardiac signaling
cardiotoxicity
doxorubicin
soy
vegetarian/vegan diet
amino acids
dietary ingredients
performance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566476003321
Kreider Richard B  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immune Checkpoint Molecules and Cancer Immunotherapy
Immune Checkpoint Molecules and Cancer Immunotherapy
Autore Alexandr V. Bazhin
Pubbl/distr/stampa Frontiers Media SA, 2019
Descrizione fisica 1 electronic resource (197 p.)
Collana Frontiers Research Topics
Soggetto non controllato CTLA-4 (CD152)
checkpoint blockade
Immunosuppression
cancer immunotherapy
PD-1 (CD279)
Tumor Microenvironment
Metabolic checkpoints
immune checkpoint molecules
cytotoxic T lymphocytes
PDL1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910345964303321
Alexandr V. Bazhin  
Frontiers Media SA, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunogenic Cell Death in Cancer: From Benchside Research to Bedside
Immunogenic Cell Death in Cancer: From Benchside Research to Bedside
Autore Abhishek D. Garg
Pubbl/distr/stampa Frontiers Media SA, 2016
Descrizione fisica 1 electronic resource (145 p.)
Collana Frontiers Research Topics
Soggetto topico Cell Death
Apoptosis
Monitoring, Immunologic
Genes, Tumor Suppressor
Immunogenic Cell Death
Neoplasms
Soggetto non controllato cancer immunology
immunocontexture
prognostic/predictive biomarker
immunosurveillance
DAMPs
patient immunology
cancer immunotherapy
Cell Death
anti-tumor immunity
danger signals
Apoptosis
necroptosis
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Immunogenic Cell Death in Cancer
Record Nr. UNINA-9910163538103321
Abhishek D. Garg  
Frontiers Media SA, 2016
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunotherapy, Tumor Microenvironment and Survival Signaling
Immunotherapy, Tumor Microenvironment and Survival Signaling
Autore Golubovskaya Vita
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (376 p.)
Soggetto topico Medicine
Clinical & internal medicine
Soggetto non controllato Autophagy
colorectal cancer
immunotherapy
tumor stroma
tumor microenvironment
immune checkpoint inhibitors
chemotherapy
tyrosine kinase inhibitors
angiogenesis
check point inhibitors
programmed cell death protein 1
programmed cell death 1 ligand 1
cardiotoxicity
lung metastasis
CAR-T
hypoxia
tumor
microenvironment
CD19
BCMA
cancer
melanoma
immune escape
antigen loss
chimeric antigen receptor
electroporation
lentivirus
lentiviral transduction
macrophages
leukemia cells
lytic peptides
targeted therapy
dendritic cells
pathogenesis
risk factors
breast cancer
resistance
checkpoint
targeted treatment
personalized medicine
pediatric solid tumors
chimeric antigen receptors
cancer vaccines
oncolytic viral therapy
immunomodulation
DCLK1
tumor stem cells
clonogenicity
mitochondria
mitochondrial transfer
tunneling nanotubes
triple-negative breast cancer
immune checkpoint inhibitor
combination therapy
cancer nanomedicine
tumor antigens
cancer metabolism
cancer immunotherapy
nanoparticles
immunotherapeutic agent
immunomodulators
tuft cells
cancer stem cells
immunotherapies
myeloid-derived suppressor cells
regulatory T cells
crosstalk
tumor immune evasion
cell-cell contact
β2 integrins
CD18
CD11
CAR-T cells
CD37
cell therapy
tumor antigen
lymphoma
CAR macrophage
CAR T cell
solid tumors
immunometabolism
miRNA
immunogenic cell death
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580205403321
Golubovskaya Vita  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Strategies Aimed to Boost NK Cell-based Immunotherapy of Cancer
Molecular Strategies Aimed to Boost NK Cell-based Immunotherapy of Cancer
Autore Cifaldi Loredana
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 electronic resource (146 p.)
Soggetto topico Medicine
Immunology
Soggetto non controllato NK cells
NK cell-based immunotherapy
cancer immunotherapy
immune checkpoint inhibitors
adoptive transfer of NK and CAR-NK cells
ligands for NK cell-activating receptors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557249903321
Cifaldi Loredana  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Prognostic and Predictive Markers in Cancer Progression
New Prognostic and Predictive Markers in Cancer Progression
Autore Costantini Susan
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (294 p.)
Soggetto topico Medicine
Soggetto non controllato MSI2
OSCC
oral cancer
musashi 2
prognosis
N-cadherin
EMT
breast cancer
new metastasis
eribulin
blood
biomarker
bladder cancer
immune checkpoint inhibitor
CD8+ T effector cells
microRNA
biomarkers
head and neck cancer
laryngeal cancer
prediction
metastasis
lifestyle habit
chemo-/radio resistance
therapeutic target
AKT
AR
castration-resistant prostate cancer (CRPC)
MAPK
mTOR
PI3K
prostate cancer
therapeutic resistance
WNT
miRNA
melanoma
melanoma resistance to MAPK/MEK inhibitors
resistance to immune checkpoint inhibitors
TNBC
BRCA1/2
HRR
PDL1
TILs
PI3KCA
PTEN
CTCs
CSC
pancreatic cancer
K-RAS oncogene
oncogene dependency
targeted therapies
genomic mutations
transcriptomics
metabolomics
selenoproteins
cancer
HUB nodes
major histocompatibility complex (MHC)
human leukocyte antigen (HLA)
antigen processing machinery (APM) molecules
carcinogenesis
tumor predisposition
cancer immunotherapy
pheochromocytoma
paraganglioma
head and neck neoplasms
head and neck tumors
genetic syndromes
mutations
hyperglycemia
cardioncology
nivolumab
cytokines
cardiotoxicity
acetyltransferase
cancer prognosis
NAA10
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557794803321
Costantini Susan  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Oncolytic Virus Immunotherapy
Oncolytic Virus Immunotherapy
Autore Marchini Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (366 p.)
Soggetto topico Medicine
Clinical & internal medicine
Soggetto non controllato oncolytic viruses
melanoma
immunotherapy
checkpoint inhibitors
combinatory therapy
reovirus
oncolytic virus
adenovirus
oncolytic
virotherapy
targeting
immunogenic cell death
αvβ6 integrin
oncolytic adenovirus
cancer immunotherapy
multi-stage
immunostimulatory
arming
HSV-1
clinical trials
newcastle disease virus
NDV
cancer
immune checkpoint inhibitor
PD-1
PD-L1
CTLA-4
type I interferon
herpes simplex virus
retargeted virus
tropism retargeting
tumor
checkpoint inhibitor
vaccination
antigen-agnostic vaccination
HER2
parvovirus
tumor microenvironment
combination therapy
glioblastoma
pancreatic cancer
colorectal cancer
measles virus
vector engineering
immune checkpoint blockade
antitumor immune response
delivery
genetic modification
biomarkers
personalized oncolyticvirotherapy
class I HLA
immunosurveillance
immunoediting
oncogenic signaling
RAS
DNA methyltransferase inhibitor (DNMTi)
viral mimicry
epigenetic silencing
adoptive T cell therapy
CAR T cell
pancreatic ductal adenocarcinoma
vesicular stomatitis virus
small molecule
cancer immune therapy
cancer therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566462203321
Marchini Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui